Travere Therapeutics Inc. (TVTX)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
56. 71
+1.43
+2.5868%
$
5.31B Market Cap
- P/E Ratio
- Div Yield
1.46M Volume
-3.18 Eps
$ 55.28
Previous Close 
Want to track TVTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Travere Therapeutics Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Vamil Divan Guggenheim | 10,238.92 | $579,420.69 | $583,209.09 | $3,788.4 | 0.65% |
 Tyler Van Buren TD Cowen | 452.24 | $20,455.44 | $25,660.27 | $5,204.83 | 25.44% |
 Yigal Nochomovitz Citigroup | 92.47 | $4,987.57 | $5,111.51 | $123.94 | 2.48% |
